As shown in Figure 8, MIR503HG inhibited SPI1-mediated transcriptional activation of TMEFF1 by binding to SPI1, and suppressed the expression of TMEFF1, thus hindering the progression of ovarian cancer. This evidence concerns the gene MIR503HG and ovarian carcinoma.